AIDX 424B3: SEC filing
20/20 Biolabs, Inc.
Filed with the SEC on · accession 0001213900-26-090758
AIDX filed a 424B3 (prospectus (offering)) with the SEC on Aug 17, 2026. The final terms of an offering of shares or bonds. The stock moved -1.0% by the first close after the filing.
Summary of the filing
20/20 Biolabs, Inc. filed a prospectus supplement for the resale of up to 10,105,000 shares of common stock by selling stockholders, incorporating its quarterly report for the period ended June 30, 2026.
Key details
How AIDX stock reacted
Close before
$0.56
Aug 14, 2026
First close after
-0.99%
$0.55
5 trading days
-0.27%
$0.55
Since filing
-66.71%
$0.18
✦ Ask GOAX AI about this filing — what it means for AIDX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AIDX?
Click hereFrequently asked questions
What did AIDX file with the SEC on Aug 17, 2026?
AIDX filed a 424B3 (SEC filing). 20/20 Biolabs, Inc. filed a prospectus supplement for the resale of up to 10,105,000 shares of common stock by selling stockholders, incorporating its quarterly report for the period ended June 30, 2026.
How do I read a 424B3?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B3 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did AIDX stock react to this filing?
AIDX closed at $0.56 before the filing and $0.55 on Aug 17, 2026 (-0.99%). Five trading days later: $0.55 (-0.27%).
Other AIDX SEC filings
Get alerts when AIDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days